Home Business Anxu Biology: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments_ Securities Times Network

Anxu Biology: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments_ Securities Times Network

by admin
</p> <p> Anxu Biology: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments_ Securities Times Network<br /> news.google.com/__i/rss/rd/articles/images/public.css” />news.google.com/__i/rss/rd/articles/images/share_style0_16.css” />

news.google.com/__i/rss/rd/articles/images/css1.css” rel=”stylesheet” type=”text/css” />

Home > News > e company

Anxu Biology: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments

2022-01-12 18:18

Source: Securities Times e Company

Author: Lee Jae-san

Securities Times · e company

Lee Jae-san

2022-01-12 18:18

Securities Times e company news, Anxu Bio (688075) announced on the evening of January 11 that with the outbreak of the new crown epidemic, the demand for real-time detection reagents and testing instruments in various countries around the world has greatly increased, especially in foreign markets. The company plans to invest in the construction of in vitro diagnostic reagents and diagnostic instrument R&D and production projects, which will be implemented by a wholly-owned subsidiary, Xumin Biology, with an estimated total investment of 508 million yuan. The company has raised a total of 597 million yuan, and plans to use part of the raised funds to invest in the project. After the project is completed, it will further expand the company’s production scale and improve the automation level of the production line.

Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.

  • Securities Times APP
  • WeChat public account


  • 4065645

    Anxu Biology: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments

    6885

    e company

    news

    1445

    Lee Jae-san

    2022-01-12

    0 comment
    0

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy